LENZ·52635N103·US·equity·Healthcare - Biotechnology-Activist
LENZ (LENZ THERAPEUTICS INC) is held by 93 institutional investors as of Q4 2025. Net institutional sentiment: Mixed.
This is taking longer than usual. Please try again in a moment.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer